Focal Medical, Inc. (acquired by Continuity Biosciences)
We are developing novel targeted therapeutic products based on our innovative local drug-delivery technology platforms.
4 employees · est. 2015 · Cary, United States
Tango Therapeutics
Targeting tumor suppressor loss to unmask vulnerabilities for the next generation of precision medicines.
157 employees · est. 2017 · Boston, United States
Focal Medical, Inc. (acquired by Continuity Biosciences) is the older company (2015 vs 2017); Tango Therapeutics is the larger of the two.
Side-by-Side Comparison
| Metric | Focal Medical, Inc. (acquired by Continuity Biosciences) | Tango Therapeutics |
|---|---|---|
| Founded | ||
| Founded | 2015 older | 2017 |
| Headquarters | ||
| Headquarters | Cary, United States | Boston, United States |
| Employees | ||
| Employees | 4 | 157 larger |
| Industry | ||
| Industry | Biopharma, Biotechnology, Medical Devices | Biotechnology, Health Care, Health and Wellness |
| Funding Stage | ||
| Funding Stage | Series A | Post Ipo Equity |
| Total Funding | ||
| Total Funding | $12.47M | $351.00M |
| Funding Rounds | ||
| Funding Rounds | 2 | 4 |
| Services | ||
| Services | Development of Energy-Based Drug Delivery Systems, Local Drug Delivery for Solid Tumors, Clinical Research and Trials for Oncology Therapeutics, Laparoscopic Implantation Techniques | Medicine Development, Genetically Targeted Therapies, Cancer Treatment Research, Clinical Trials, Drug Pipeline Expansion, Biotechnology Innovations |
| Target Customers | ||
| Target Customers | Oncologists, Cancer Treatment Centers, Clinical Research Organizations, Patients with Intractable Solid Tumors, Biomedical Engineers | Cancer Patients, Oncologists, Healthcare Providers, Pharmaceutical Researchers, Biopharma Investors |
| Taxonomy | ||
| Taxonomy | Biopharmaceutical, Local Drug-delivery, Targeted Therapeutics, Innovative Technology, Pancreatic Cancer Treatment, Non-circulatory Drug Delivery, Patent Protected, Oncology, Gemcitabine Delivery, Advanced Chemotherapy | Clinical-stage, Precision Medicine, Cancer Treatment, Tumor Suppressor Targeting, Synthetic Lethality, CRISPR-based Discovery, DNA Sequencing, Immuno-oncology, Oncogenic Drivers, Immune Evasion, Functional Genomics, Drug Discovery, Targeted Therapies, Novel Drug Targets |
| Website | ||
| Website | focalmedical.co | tangotx.com |
About Focal Medical, Inc. (acquired by Continuity Biosciences)
Focal Medical, Inc., recently acquired by Continuity Biosciences, is a pioneering company in the biopharmaceutical sector, known for its development of targeted therapeutic products through innovative local drug-delivery technologies. Founded in 2015, this United States-based company has made signif...
About Tango Therapeutics
Tango Therapeutics is a clinical-stage biotechnology company, established in 2017, focused on developing precision medicines to target cancer by exploiting tumor suppressor loss. Its mission is encapsulated in the slogan: "Targeting tumor suppressor loss to unmask vulnerabilities for the next genera...
We will tell you when either one moves
BounceWatch watches Focal Medical, Inc. (acquired by Continuity Biosciences) and Tango Therapeutics for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.
Funding, hiring, leadership and stack changes at Focal Medical, Inc. (a... and Tango Therapeutics — by email.
Frequently Asked Questions
Compare Focal Medical, Inc. (acquired by Continuity Biosciences) with someone else
Start typing a company name or domain.
Compiled from the BounceWatch company index. We last looked at Focal Medical, Inc. (acquired by Continuity Biosciences) on 11 Mar 2026, and Tango Therapeutics on 15 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
